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Summary
Background: It is well established that growth factors play a critical role in the healing process
of connective tissues. To our knowledge, there are no studies in literature concerning the
inﬂuence of PRP on growth factors expression.
Hypothesis: The aim of this study was to assess the effect of a single application of platelet
rich plasma (PRP) gel in a patellar tendon defect on the spatial and temporal expression of
Insulin-like Growth Factor 1 (IGF-1) during tendon healing.
Materials and methods: Twenty-four animals were randomized to receive PRP (PRPFast,
Bioteck) in a gel form (PRP group) and 24 to serve as untreated controls (Control group). A
defect of 3mm× 10mm was surgically created on the tendon under general anaesthetic and in
the PRP group, PRP gel was applied to ﬁll the tendon defect whereas no treatment was applied
in the control group. Six animals (12 limbs) from each treatment-group were sacriﬁced after
one, two, three and four weeks following treatment. Histological and immunohistochemical
staining were performed.
Results: Histology revealed a faster healing process in the tendons of PRP group in
comparison with the controls. In the ﬁrst 2 weeks of healing, IGF-1 was found intracel-
lularly in various type cells, whereas in the last 2 weeks of healing, IGF-1 was detected
mainly in tenocytes. Both cytoplasmic and nuclear expressions were present, whereas
the larger amounts of immunoexpression were localized in both epitenon and endotenon.
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A superior expression of IGF-1 was seen in PRP group compared with controls (p < 0.0001) in
both the epitenon and endotenon at each time point except at 4th week of healing where a
superior expression of IGF-1 was shown in the endotenon of control group, compared to the
PRP group (p < 0.0001).
Conclusion: PRP may improve tendon defect healing by overexpression of IGF-1.
Level of evidence: Laboratory control animal study.
© 2010 Published by Elsevier Masson SAS.
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of PRP was collected for every 8ml of blood. The PRP wasntroduction
n injury to the soft connective tissues such as the tendons
esults to the initiation of a complex wound healing cascade
nd ﬁnally the formation of a scar. It is known that the prop-
rties of this scar tissue are inferior when compared to those
f normal tissue [1,2]. Therefore, investigators have utilized
variety of tissue engineering techniques in an attempt to
mprove these inferior properties. One of these techniques
s platelet-rich plasma (PRP). PRP provides a pool of con-
entrated growth factors derived from platelets which are
nvolved in the healing process of tissue defects as well as
rowth. One of these factors is Insulin Growth Factor 1 (IGF-
) which is a well established factor in the process of tissue
ealing.
Although there are a few studies which have demon-
trated the positive effect of PRP in tendon healing [3], the
ay that PRP acts is not well documented. We have previ-
usly shown that PRP promotes angiogenesis in a patellar
endon defect in rabbits [4]. The aim of the study was to
ssess the effect on the spatial and temporal expression of
nsulin Growth Factor 1 (IGF-1) in the early phase of tendon
ealing in the same experimental model following applica-
ion of PRP. Our null hypothesis was that PRP has no inﬂuence
n the spatial and temporal expression of IGF-1.
aterials and methods
ll procedures in the animal experiments were approved by
he regional ethical board, while institutional guidelines for
he care and treatment of laboratory animals were adhered
o. We used 48 skeletally mature New Zealand White rab-
its, weighing an average of 3.5 kg. During the surgical
rocedure, a full thickness window defect of 3× 10mm was
reated in the mid-part of the patellar tendon. Twenty-four
nimals were randomized to receive PRP (PRPFast, Bioteck)
n a gel form (PRP group) and 24 to serve as untreated con-
rols (Control group). In the PRP group, PRP gel was applied
nd ﬁlled the tendon defect, whereas no treatment was
pplied in the control group. Six animals (12 limbs) from
ach treatment-group were sacriﬁced after one, two, three
nd four weeks following treatment.
urgical procedurehe rabbits were anaesthetized with an intramuscular
njection of xylazine (Rompun® Injectable, Bayer) at a
osage of 5—7mg/kg and 0.15mg of atropine (DEMO S.A.).
en to 15min later, ketamine (Imalgene®, Rhone Merieux,
a
p
a
grance) at a dosage of 12—15mg/kg was injected intra-
uscularly. During surgery, supplemental sedation was
iven administered as required. Local anaesthesia 1ml
f a 2% lidocaine-adrenaline solution (AstraZeneca, UK)
as applied at regular intervals at the site of inci-
ions.
The surgical procedure was performed according to the
nimal model described by Anaguchi et al. [5]. The skin of
he right knee was shaved and the operation was performed
nder aseptic conditions. Following that, a longitudinal skin
ncision was made on the skin overlying the middle of the
atellar tendon. The superﬁcial surrounding fascia was cut
ongitudinally to expose the patellar tendon. Thereafter,
he deep fascia overlying the tendon was opened and a full
hickness, 3mm wide, and 10mm long tendon substance was
xcised from the central portion of the patellar tendon with
specially designed knife that had two stainless-steel surgi-
al blades. The 3-mm width of the defect is approximately
qual to one-third of the width of the tendon. Four mark-
rs were placed at the corners of the defect with 5-0 nylon
utures to identify the location of the resected portion.
he PRP gel was then applied and ﬁlled the tendon defect.
he overlaying fascia was closed with a running suture of
-0 nylon so that PRP gel applied into the resected por-
ion would not ﬂow out. Skin was closed with clips. The
ame procedure was performed in the opposite limb and the
ame procedure was performed in both limbs in the control
roup, without the application of PRP into the patellar ten-
on defect. No immobilization was applied after surgery,
nd the rabbits were allowed unrestricted daily activities in
heir cages.
RP preparation
ight milliliters of blood from an ear vein was collected in
tube, immediately after general anaesthesia. The blood
as allowed to stand for 15min in order to reduce platelets
ctivation during centrifugation. Once centrifugation was
omplete, the upper half was considered Platelet Poor
lasma (PPP) and was removed by using sterile pipettes. The
ower half, the PRP, was retrieved using a pipette by aspi-
ating up to the interphase zone (consisting of blood cells)
nd was then placed into another glass tube. Two milliliterspplied in a gel form, manufactured by adding 0.5ml of
rocoagulant solution in the tube with the liquid PRP and
llowing approximately 15min for the solution to become a
el.
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cFigure 1 Presentation of a patellar tendon specimen (1st w
Macroscopically, a blood clot with a granular tissue is ﬁlling the
is more prominent.
Sample harvesting
At each time point, the animals were sacriﬁced with an
overdose of intracardiac injection of 10% KCl solution under
general anaesthesia. The entire patellar tendon was then
removed and dissected free from other tissues (Fig. 1).
Then, each tissue was ﬁxed in a 10% buffered formalin solu-
tion and cast in a parafﬁn block. The tendon was sectioned
transversely to the longitudinal axis, and stained with hema-
toxylin and eosin. From each tendon repair site, 12 parafﬁn
sections were made. Of them, three sections were sub-
jected to microscopic examination, while the other nine
were immunostained with an anti-IGF-1 primary antibody.
All sections were randomly selected and analyzed at both
the endotenon as well as epitenon sites by a single patholo-
gist, who was blinded to the treatment groups.
Immunohistochemical staining
Immunohistochemistry was applied on 4m thick sections
which were obtained from the parafﬁn blocks and placed
on positively charged glass slides. The last ones were left
to dry at 37 ◦C overnight. Deparafﬁnization was achieved
using xylene, followed by rehydration through graded alco-
hols. For the antigen retrieval, slides were treated in
citrate buffered solution 10mM at pH 6.0 in two cycles of
15min each. Endogenous peroxidase activity was blocked by
immersing the slides in 3% hydrogen peroxide for 20min at
room temperature. Primary antigen, (anti-IGF-1 clone OBT
1090G, AbD Serotec, US), was applied in a dilution 1:100
overnight. A two-step technique (Envision K-5000, Dako
Glostrup, Denmark) was used and the bound antibodies were
visualized using 3,3′ diaminobenzidine tetrahydrochloride
(DAB) as chromogen. Hematoxylin was used for counter-
staining. For negative controls, the primary antibody was
omitted and replaced by buffered saline serum. For the
quantitative analysis, the slides were digitized using a light
microscope (Nikon Eclipse 80i, Nikon Corp, Tokyo, Japan)
and the images were montaged with the appropriate soft-
ware (Adobe Photosop CS3®). Then, using semi-automated
t
w
o
h
tpostoperatively) from (a) control group and (b) PRP group.
in the control group whilst in the PRP group the granular tissue
omputerized image analysis with Image ProPlus v5.1 (Media
ybernetics, MD, USA), we evaluated the density of brown
iaminobenzidine (DAB) staining, a well-established tech-
ique as described in Zaﬁrellis et al. [6]. Values for color
ensity have a range from 0 (black) to 255 (white). Posi-
ive and negative control slides were used for the optimal
eparation of brown and blue stained areas.
tatistical analysis
ll results are expressed as mean± SD. Signiﬁcant differ-
nces among groups were evaluated using the Mann-Whitney
test. A difference of p < 0.05 was considered to be statis-
ically signiﬁcant (SPSS 11.5.0).
esults
istology
he endotenon had a normal appearance in both groups at all
ime-points, while the epitenon was thickened from two to
—6 cell layers by the 4th week time-point. Thickening was
ore obvious near the repair site. At the 1st and 2nd week
ime-points, the histological appearance of the repair site
as similar in both groups. A blood clot with a granular tissue
lled the gap at the 1st week (Fig. 1) with intense mononu-
lear inﬁltrates, newly formed vessels and collagen ﬁbers
ere mixed with plumbed tenocytes which also lost their
ormal orientation (Fig. 2). At the 2nd week, ﬁbroblast-like
ells were obvious and there was inconsistent neoformation
f blood vessels with rare presence of collagen ﬁbers and
brosis. At the 3rd week time-point, there were noticeable
ifferences between the two groups. In the control group
he formed tissue remained more immature, with a less
ompact synthesis absence of tenocyte longitudinal orienta-
ion. On the other hand, in PRP group the tissue was denser
ith fewer less elastic ﬁbers remaining and better tenocyte
rientation. Finally, at the 4th week time-point an almost
ealed tendon with some cellular activity was observed in
he control group and a completely healed tendon in PRP
384 D.N. Lyras et al.
Figure 2 Patellar tendon at 1st week from PRP group
(Hematoxylin-Eosin stain). (A) Low power ﬁeld (20× original
magniﬁcation) showing thickening of the epitenon cell layer
which ﬁlls the wounded site. (B) Under higher magniﬁcation
(200×), a granular tissue is identiﬁed (arrows) around the repair
site, while the tendon (arrowheads) is disorganized.
Figure 4 Presentation of IGF-1 expression in the areas of
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expression at the 4th week (Fig. 3). Furthermore, in controlgroup (no clear visible border between repair site and rest
of tendon; absent cellular activity). Furthermore, in PRP
group the repair tissue which was bridging the gap became
more ﬁbrous with increased numbers of more distinct ori-
ented ﬁbroblasts which established a more ﬁrm lesion. The
number of vessels decreased in both groups indicating the
completion of healing process.
g
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w
Figure 3 Immunohistochemical detection of IGF-1 in the endoten
original magniﬁcations. PRP group (right column) expresses larger am
while the last one has stronger expression than PRP group at 4th wepitenon and endotenon in control group during the healing
eriod. Note that large values of the color density indicate low
GF-1 expression and conversely.
mmunohistochemistry
patial expression of IGF-1
n the ﬁrst 2 weeks of healing, IGF-1 was found mainly in
nﬂammatory cells, endothelial cells, macrophages from the
ranular tissue which ﬁlled the surgical gap and in irreg-
larly shaped tenocytes. In the last 2 weeks of healing,
GF-1 was detected mainly in tenocytes. Both cytoplas-
ic and nuclear expressions were present, whereas the
arger amounts of immunoexpression were localized in both
pitenon and endotenon.
emporal expression of IGF-1
gradual decrease of IGF-1 was observed during the healing
eriod in both groups. PRP group showed a superior expres-
ion of IGF-1 during the ﬁrst 3 weeks of healing in comparison
ith the controls, whereas control group showed a superiorroup during the ﬁrst 3 weeks of healing a superior expres-
ion of IGF-1 was demonstrated in epitenon in comparison
ith endotenon (p < 0.0001), whereas at 4th week a superior
on, as represented by brown diaminobenzidine staining, 200×
ounts of IGF-1 at the ﬁrst 3 weeks compared to control group,
ek.
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Table 1 Image analysis of color density of the areas of epitenon and endotenon positively stained with IGF-1 in both control
and PRP groups. Note that large values of the color density indicate low IGF-1 expression and conversely.
Control
Healing period Epitenon mean color density± SD Endotenon mean color density± SD p*
1st week 91.67 ± 10.22 156.39 ± 12.24 < 0.0001
2nd week 94.62 ± 9.42 162.48 ± 12.83 < 0.0001
3rd week 113.45 ± 6.28 183.67 ± 9.75 < 0.0001
4th week 167.92 ± 12.13 103.31 ± 9.25 < 0.0001
PRP
Healing period EpitenonMean color density± SD EndotenonMean color density± SD p*
1st week 65.77 ± 6.53 124.32 ± 12.43 < 0.0001
2nd week 69.54 ± 7.54 129.76 ± 7.46 < 0.0001
s.
D
O
i
A
s
during the ﬁrst 3 weeks of healing. At the 4th week, PRP
group showed a superior expression of IGF-1 in epitenon,
in comparison with endotenon. Furthermore, histological3rd week 90.33 ± 3.98
4th week 119.76 ± 11.62
*p < 0.05 indicates a signiﬁcant difference between the two group
expression was showed in endotenon (p < 0.0001) (Table 1,
Fig. 4). In PRP group, IGF-1 was signiﬁcantly increased in
the epitenon in comparison with the endotenon in the whole
healing period (p < 0.0001) (Table 1, Figs. 5 and 6).
In the ﬁrst 3 weeks of healing, IGF-1 in PRP group was
signiﬁcantly overexpressed in comparison with the con-
trols in both epitenon and endotenon (p < 0.0001) (Table 2,
Figs. 7 and 8). At 4th week, although IGF-1 in PRP group
was signiﬁcantly underexpressed in endotenon (p < 0.0001),
there was a persistent signiﬁcant increase of the growth
factor in epitenon in comparison with the control group
(p < 0.0001) (Table 2, Fig. 7).
e
c
Figure 5 Patellar tendon immunostained for IGF-1 2 weeks after
in the epitenon cell layer compared to endotenon under 20× origina
and (C) from epitenon under 200× magniﬁcation.151.01 ± 10.71 < 0.0001
184.33 ± 14.12 < 0.0001
iscussion
ur results showed that IGF-1 expression was present dur-
ng the whole healing process in both PRP and control group.
superior expression of IGF-1 in the epitenon was demon-
trated, in comparison with the endotenon in both groupsvaluation revealed a superior healing process in PRP group
ompared with the controls.
surgery. (A) demonstrates stronger positivity for the antibody
l magniﬁcation. (B) A more detailed snapshot from endotenon
386 D.N. Lyras et al.
Table 2 Comparisons of the expression of IGF-1 between PRP and control group in both the area of epitenon and endotenon.
Note that large values of the color density indicate low IGF-1 expression and conversely.
Epitenon
Healing period Control mean color density± SD PRP mean color density± SD p*
1st week 91.67 ± 10.22 65.77 ± 6.53 < 0.0001
2nd week 94.62 ± 9.42 69.54 ± 7.54 < 0.0001
3rd week 113.45 ± 6.28 90.33 ± 3.98 < 0.0001
4th week 167.92 ± 12.13 119.76 ± 11.62 < 0.0001
Endotenon
Healing period Control mean color density± SD PRP mean color density± SD p*
1st week 156.39 ± 12.24 124.32 ± 12.43 < 0.0001
2nd week 162.48 ± 12.83 129.76 ± 7.46 < 0.0001
3rd week 183.67 ± 9.75 151.01 ± 10.71 < 0.0001
4th week 103.31 ± 9.25 184.33 ± 14.12 < 0.0001
*p < 0.05 indicates a signiﬁcant difference between the two groups.
Figure 6 IGF-1 expression in the areas of epitenon and
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ondotenon in PRP group during the healing period. Note that
arge values of the color density indicate low IGF-1 expression
nd conversely.The immunohistochemical expression of IGF-1 in the
hole early phase of healing, the intracellular expression
n various cell types, the localization of the growth factor in
he epitenon and the repair site, and the gradually decrease
igure 7 Presentation of the expression of IGF-1 in PRP and
ontrol group in the area of epitenon. Note that large values of
he color density indicate low IGF-1 expression and conversely.
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ligure 8 Presentation of the expression of IGF-1 in PRP and
ontrol group in the area of endotenon. Note that large values of
he color density indicate low IGF-1 expression and conversely.
f the expression of IGF-1 in both groups, as demonstrated
n our study, are in agreement with previous reports [7—9].
Furthermore, the superior expression of IGF-1 in the
pitenon, in comparison with the endotenon was previ-
usly explained by Gelberman et al. They demonstrated that
hen no sutures were placed in the tendon’s cut edges, and
o immobilization was applied postoperatively, there was
inimal response from the endotenon and a greater initial
esponse from epitenon ﬁbroblasts [10,11].
Another important ﬁnding in our study is that at the 4th
eek, PRP alter the spatial expression of IGF-1, demon-
trating a superior expression in epitenon, whereas controls
howed a superior expression in endotenon. Sharma and
affulli suggested that at the initial stage of the healing
rocess, collagen is produced by epitenon cells, whereas
ndotenon cells synthesized collagen later [12]. It is known
hat IGF-1 is a stimulator of collagen production [13], and
he inversion of this phenomenon in the PRP group suggests a
ole for PRP in mechanisms of tendon healing. Furthermore,
GF-1 is known to be a potent stimulator of cell proliferation
13]. The change in the IGF-1 expression in the endotenon
s observed in our study seems to be in keeping with cel-
ular activity. For example, at the 4th week in the PRP
[[
[
[
[
[
[
[
2007;25:81—91.
[18] Lyras DN, Kazakos K, Verettas D, Botaitis S, Agrogiannis G,IgF expression in tendon healing early phase
group where no cellularity was histologically found, the IGF-
1 expression is lower than the control group where some
cellularity is still present suggestive of a degree of healing
process. The most likely explanation is that PRP provides a
pool of growth factors (including IGF-1) that help expedite
the healing process which certainly seems to happen at a
faster rate in histological terms. Correlation between IGF-1
expression and cellularity is more difﬁcult to assess in the
epitenon as there was a small increase in the number of
cell layers in both groups at 4 weeks which indicate cellular
activity but difﬁcult to make further assessments.
The positive effect of PRP in tendon healing was
previously showed in vitro and in vivo. In a study on
humans, tenocytes cultures was demonstrated that PRP
stimulates cell proliferation and total collagen production,
and slightly increases the expression of matrix-degrading
enzymes and endogenous growth factors [14]. On the other
hand, Kajikawa et al. showed that locally injected PRP in
a rat patellar tendon injury model is useful as an activator
of circulation-derived cells for enhancement of the initial
tendon healing process [15]. Finally, PRP promotes angio-
genesis in the healed tendon [4], whereas various studies
demonstrated the positive effect of PRP in the mechanical
properties of the healed tendon [3,16—18].
These studies are in accordance with our ﬁndings, con-
cluding that PRP enhances and accelerates the tendon
healing process. PRP contains a wide variety of growth fac-
tors. At the site of an injury, the platelets are activated
and release their growth factors and those in turn stim-
ulate the healing process. Platelets normally initiate to a
formation of scar. Tendon healing can be regarded as reﬁned
from scar formation, and it therefore seems reasonable to
assume that the addition of an increased number of platelets
might improve the process. Further investigation with pos-
sibly longer follow-up of other growth factors contained in
PRP, and biomechanical evaluation of the healed tendons
under the inﬂuence of PRP are necessary in order to under-
stand and establish the way that PRP acts in tendon healing.
Another potential clinical application of the results of this
study in combination with biomechanical and histological
data of other studies [4,18] is the healing and rehabilita-
tion timing of the surgically created patellar tendon defect
during graft harvesting for anterior cruciate ligament recon-
struction. This would obviously require appropriate clinical
trials.
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